Diseases, Conditions, Syndromes

T-cells with a license to kill viruses

A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Neuroscience

Study identifies new biomarkers of Alzheimer's disease

Recent advances in the study of proteomes (i.e., the entire range of proteins expressed by human cells and tissues) have opened new opportunities for identifying the biological markers of specific diseases or mental disorders. ...